Does IMATINIB Cause Acute graft versus host disease? 58 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Acute graft versus host disease have been filed in association with IMATINIB (Imatinib). This represents 0.1% of all adverse event reports for IMATINIB.
58
Reports of Acute graft versus host disease with IMATINIB
0.1%
of all IMATINIB reports
27
Deaths
18
Hospitalizations
How Dangerous Is Acute graft versus host disease From IMATINIB?
Of the 58 reports, 27 (46.6%) resulted in death, 18 (31.0%) required hospitalization, and 1 (1.7%) were considered life-threatening.
Is Acute graft versus host disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Acute graft versus host disease?
CYCLOSPORINE (1,043)
MYCOPHENOLATE MOFETIL (1,021)
FLUDARABINE (715)
CYCLOPHOSPHAMIDE (710)
TACROLIMUS (686)
METHOTREXATE (656)
BUSULFAN (337)
THIOTEPA (331)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (245)
RUXOLITINIB (240)
Which IMATINIB Alternatives Have Lower Acute graft versus host disease Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL